C12N 2770/10034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/10034 (Use of virus or viral component as vaccine) appears on 203 US grants and 245 published applications in this corpus.
Search patents in C12N- Granted patents
- 203
- Published applications
- 245
- Assignees
- 120
- Inventors
- 444
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 1 |
| 2002 | 7 | 3 |
| 2003 | 3 | 14 |
| 2004 | 2 | 8 |
| 2005 | 3 | 7 |
| 2006 | 4 | 6 |
| 2007 | 7 | 6 |
| 2008 | 4 | 12 |
| 2009 | 7 | 16 |
| 2010 | 8 | 11 |
| 2011 | 4 | 9 |
| 2012 | 8 | 11 |
| 2013 | 4 | 15 |
| 2014 | 10 | 16 |
| 2015 | 10 | 12 |
| 2016 | 6 | 14 |
| 2017 | 14 | 14 |
| 2018 | 18 | 15 |
| 2019 | 10 | 10 |
| 2020 | 13 | 13 |
| 2021 | 9 | 3 |
| 2022 | 8 | 8 |
| 2023 | 3 | 9 |
| 2024 | 5 | 4 |
| 2025 | 4 | 4 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- M Hyo multivalent vaccine and uses thereof16 Jun 2026US 12,653,876 B2
- N protein epitope mutation marker for preparing epitope deletion-marked vaccine strain of type II porcine reproductive and respiratory syndrome virus (PRRSV) and use thereof19 May 2026US 12,629,411 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Combination of vaccines to prophylactically treat a pig7 Apr 2026US 12,594,328 B2Intervet Inc.
- Vaccine to protect against mycoplasma hyopneumoniae3 Mar 2026US 12,564,629 B2Vaxinano SAS
- Recombinant antigen and method of making the same, isolated polynucleotide of porcine reproductive and respiratory syndrome virus (PRRSV) and immunogenic composition including the same12 Aug 2025US 12,383,613 B2National Pingtung University of Science and Technology
- Methods and compositions for vaccinating piglets against prrs-1 virus9 Jul 2026US 2026/0191945 A1Zoetis Services LLC
- Porcine interferon-like recombinant protein and use thereof9 Jul 2026US 2026/0191946 A1Bodn Biotech Inc.
- Vaccine to protect against mycoplasma hyopneumoniae28 May 2026US 2026/0144863 A1Vaxinano SAS
- Nadc34-like prrsv-2 vaccine candidate strain and application thereof2 Apr 2026US 2026/0091100 A1Yangzhou University
- Epitope and immunogen design for development of vaccines, diagnostics, and immunotherapeutics6 Nov 2025US 2025/0342906 A1Iowa State University Research Foundation, Inc.
Most cited
By later US patents
- European vaccine strains of the porcine reproductive and respiratory syndrome virus110US 5,925,359 AAkzo Nobel N. V. · 1999
- Low pathogencity PRRS live virus vaccines and methods of preparation thereof81US 5,690,940 ARegents of the University of Minnesota · 1997
- Method of growing and attenuating a viral agent associated with mystery swine disease76US 5,476,778 ABoehringer Ingelheim Animal Health, Inc. · 1995
- PRRS vaccines74US 7,368,117 B2Boehringer Ingelheim Vetmedica GmbH · 2008
- Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome71US 5,695,766 AIowa State University Research Foundation, Inc. · 1997